The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia
- PMID: 25621490
- PMCID: PMC4306550
- DOI: 10.1371/journal.pone.0117704
The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia
Abstract
Background: Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with an unclear etiology. This study aims to investigate the role of IL-23/Th17 pathway in patients with ITP.
Method: The gene expressions of IL-17, IL-23 and their receptors in ITP patients and healthy controls were analyzed by quantitative real-time PCR. ELISA was used to test the IL-17 and IL-23 levels in plasma. Flow cytometry was used to detect the frequency of Th17 cells. The correlation between plasma IL-23 and IL-17 levels, Th17 cells, platelets were analyzed. The level of Th17-related cytokines was measured by ELISA following stimulation with IL-23. Subsequently, the IL-23 and IL-17 levels were measured in patients post-treatment.
Results: The PBMCs of ITP patients showed increased mRNA expression levels in each of the following: IL-23p19, IL-12p40, IL-23R, IL-12Rβ1, IL-17A, IL-17F, and RORC. In addition, elevated Th17 cells and plasma IL-17, IL-23 levels were also observed in these ITP patients. Furthermore, it was found that IL-23 levels in plasma are positively correlated with IL-17 levels and Th17 cells, yet negatively correlated with platelet count. Following IL-23 stimulation in vitro, IL-17 levels showed significant elevation. Furthermore, both IL-23 and IL-17 levels decreased after effective treatment.
Conclusion: The IL-23/Th17 pathway may be involved in the pathogenesis of ITP through enhancement of the Th17 response. Moreover, our results suggest that the IL-23/Th17 pathway is a potential therapeutic target in future attempts of ITP treatment.
Conflict of interest statement
Figures






Similar articles
-
An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia.Platelets. 2017 May;28(3):287-294. doi: 10.1080/09537104.2016.1218454. Epub 2016 Sep 23. Platelets. 2017. PMID: 27662073
-
Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.Expert Opin Ther Targets. 2015 Jun;19(6):723-32. doi: 10.1517/14728222.2015.1016499. Expert Opin Ther Targets. 2015. PMID: 25976230
-
[High mobility group protein B1(HMGB1) promotes myeloid dendritic cell maturation and increases Th17 cell/Treg cell ratio in patients with immune primary thrombocytopenia].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025 Jan;41(1):45-50. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025. PMID: 39799424 Chinese.
-
Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia.Platelets. 2015;26(5):453-8. doi: 10.3109/09537104.2014.934217. Epub 2014 Jul 15. Platelets. 2015. PMID: 25025295
-
[Research Progress on Immune Mechanism of Immune Thrombocytopenia--Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Aug;27(4):1321-1324. doi: 10.19746/j.cnki.issn.1009-2137.2019.04.054. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019. PMID: 31418400 Review. Chinese.
Cited by
-
Lymphocyte immunophenotype in dogs with immune-mediated hematologic disease.PLoS One. 2025 Jun 17;20(6):e0326341. doi: 10.1371/journal.pone.0326341. eCollection 2025. PLoS One. 2025. PMID: 40526723 Free PMC article.
-
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP.Blood Adv. 2023 Jul 25;7(14):3710-3724. doi: 10.1182/bloodadvances.2023009949. Blood Adv. 2023. PMID: 37042947 Free PMC article. Review.
-
Biologic therapy for ulcerative colitis associated with immune thrombocytopenia.Clin J Gastroenterol. 2024 Oct;17(5):910-914. doi: 10.1007/s12328-024-02022-w. Epub 2024 Jul 31. Clin J Gastroenterol. 2024. PMID: 39085737
-
The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.Front Pediatr. 2016 Oct 19;4:102. doi: 10.3389/fped.2016.00102. eCollection 2016. Front Pediatr. 2016. PMID: 27807534 Free PMC article. Review.
-
A Blueprint for Identifying Phenotypes and Drug Targets in Complex Disorders with Empirical Dynamics.Patterns (N Y). 2020 Nov 6;1(9):100138. doi: 10.1016/j.patter.2020.100138. eCollection 2020 Dec 11. Patterns (N Y). 2020. PMID: 33336196 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources